IBDEI0G4 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7148,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,7149,0)
 ;;=E11.349^^49^479^81
 ;;^UTILITY(U,$J,358.3,7149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7149,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonprlf Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,7149,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,7149,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,7150,0)
 ;;=E11.351^^49^479^78
 ;;^UTILITY(U,$J,358.3,7150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7150,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,7150,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,7150,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,7151,0)
 ;;=E11.359^^49^479^79
 ;;^UTILITY(U,$J,358.3,7151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7151,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,7151,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,7151,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,7152,0)
 ;;=E11.610^^49^479^58
 ;;^UTILITY(U,$J,358.3,7152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7152,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,7152,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,7152,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,7153,0)
 ;;=E11.618^^49^479^55
 ;;^UTILITY(U,$J,358.3,7153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7153,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,7153,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,7153,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,7154,0)
 ;;=E11.620^^49^479^56
 ;;^UTILITY(U,$J,358.3,7154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7154,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,7154,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,7154,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,7155,0)
 ;;=E11.621^^49^479^67
 ;;^UTILITY(U,$J,358.3,7155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7155,1,3,0)
 ;;=3^Diabetes Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,7155,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,7155,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,7156,0)
 ;;=E11.622^^49^479^83
 ;;^UTILITY(U,$J,358.3,7156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7156,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,7156,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,7156,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,7157,0)
 ;;=E11.628^^49^479^82
 ;;^UTILITY(U,$J,358.3,7157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7157,1,3,0)
 ;;=3^Diabetes Type 2 w/ Skin Complications
 ;;^UTILITY(U,$J,358.3,7157,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,7157,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,7158,0)
 ;;=E11.630^^49^479^77
 ;;^UTILITY(U,$J,358.3,7158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7158,1,3,0)
 ;;=3^Diabetes Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,7158,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,7158,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,7159,0)
 ;;=E11.638^^49^479^76
 ;;^UTILITY(U,$J,358.3,7159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7159,1,3,0)
 ;;=3^Diabetes Type 2 w/ Oral Complications
 ;;^UTILITY(U,$J,358.3,7159,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,7159,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,7160,0)
 ;;=E11.69^^49^479^84
 ;;^UTILITY(U,$J,358.3,7160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7160,1,3,0)
 ;;=3^Diabetes Type 2 w/ Spec Complication NEC
 ;;^UTILITY(U,$J,358.3,7160,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,7160,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,7161,0)
 ;;=E11.8^^49^479^85
 ;;^UTILITY(U,$J,358.3,7161,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,7161,1,3,0)
 ;;=3^Diabetes Type 2 w/ Unspec Complications
